The Dexcom G7 is a next-generation continuous glucose monitoring (CGM) system that is redefining diabetes management through real-time data, ease of use, and clinical accuracy. The Dexcom G7 delivers real-time glucose readings every 5 minutes, integrates with popular smart devices, and requires no routine fingersticks—features that significantly enhance patient convenience and compliance.
With a 30-minute warm-up time and all-in-one wearable sensor and transmitter, the G7 simplifies onboarding and use for both patients and care teams. Its customizable alerts help prevent both high and low glucose events, and pharmacies can play a key role in patient education and support for G7 users. By equipping patients with tools like Dexcom G7, pharmacies can strengthen their clinical footprint in chronic care management, particularly for those managing Type 1 and Type 2 diabetes.
Key advantages at a glance:
- 60% smaller than G6, with a more comfortable, discreet profile
- Seamless integration with iOS and Android devices, as well as compatible insulin delivery systems
- FDA-cleared for ages 2 and up, making it accessible for pediatric through geriatric patients
- Shareable data for up to 10 followers via Dexcom Follow app—ideal for caregivers and clinicians
- Opportunities for pharmacists to deliver training, reimbursement guidance, and ongoing monitoring support
Customizable alerts—such as the predictive low alert that provides a 20-minute warning—give patients time to act before glucose dips dangerously. And with the ability to share data with up to 10 followers, the G7 strengthens connections between patients, caregivers, and care teams, enhancing collaborative care models.
